4991 - 5000 of 7915 Results
Title
Year
- The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease2019OPENTitle: The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 3Start Page: 553End Page: 563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191648Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191648?id=journal-of-parkinsons-disease%2Fjpd191648Citation Count: 31
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls2019OPENTitle: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controlsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1392End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27807Best OA location URL: https://europepmc.org/articles/pmc6754269?pdf=renderCitation Count: 24
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism2019RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 36
- Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort.2019OPENTitle: Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 8Start Page: 1111End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000583Best OA location URL: https://doi.org/10.1037/neu0000583Citation Count: 26
- Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderly2019OPENTitle: Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderlyJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 1Start Page: 160End Page: 167Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14050Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14050Citation Count: 16
-
OPENTitle: Parkinson’s progression prediction using machine learning and serum cytokinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0086-4Best OA location URL: https://www.nature.com/articles/s41531-019-0086-4.pdfCitation Count: 82
- Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis2019OPENTitle: Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysisJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 1248End Page: 1257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-019-0457-5Best OA location URL: https://europepmc.org/articles/pmc6662627?pdf=renderCitation Count: 215
- Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s disease2019OPENTitle: Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3129End Page: 3143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz239Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3129/30063714/awz239.pdfCitation Count: 123
- The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin2019OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 18
- The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology2019OPENTitle: The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathologyJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 1Start Page: 43End Page: 50Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14032Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14032Citation Count: 16